Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 26;4(3):txaa158.
doi: 10.1093/tas/txaa158. eCollection 2020 Jul.

Effects of increasing doses of trenbolone acetate and estradiol on finishing phase growth performance, carcass trait responses, and serum metabolites in beef steers following implantation

Affiliations

Effects of increasing doses of trenbolone acetate and estradiol on finishing phase growth performance, carcass trait responses, and serum metabolites in beef steers following implantation

Dathan T Smerchek et al. Transl Anim Sci. .

Abstract

Yearling Simmental × Angus crossbred beef steers (n = 240; allotment BW = 365 ± 22.5 kg) from a South Dakota auction facility were transported 117 km to Brookings, SD and used in a randomized complete block design feedlot study to evaluate the effects of implants (both from Zoetis, Parsippany, NJ) containing increasing doses of trenbolone acetate (TBA) and estradiol benzoate (EB) administered 124 d prior to harvest have on finishing phase growth performance, carcass characteristics, and serum concentrations of urea-N (SUN) and insulin-like growth factor I (IGF-I). Thirty pens (10 pens/treatment) were assigned to 1 of 3 treatments: 1) negative control given no implant (NI); 2) a steroidal implant containing 100 mg TBA and 14 mg EB administered subcutaneously in the center one-third of the ear on day 1 (Synovex Choice, Zoetis, Parsippany, NJ; CH); 3) a steroidal implant containing 200 mg TBA and 28 mg EB administered subcutaneously in the center one-third of the ear on day 1 (Synovex Plus, Zoetis; PL). Cattle were fed for 124 d post-implantation. Steers were fed a common diet throughout the study. Treatment effects were evaluated by the use of orthogonal polynomials. Pen was the experimental unit for all analyses; an α of 0.05 determined significance. There was a quadratic effect (P = 0.01) on carcass-adjusted final BW. Increasing doses of TBA and EB resulted in a linear increase for both average daily gain (P = 0.01) and dry matter intake (P = 0.02). A quadratic effect on gain-to-feed ratio was observed (P = 0.01). No quadratic (P ≥ 0.40) or linear (P ≥ 0.14) effects were observed for dressing percentage, rib fat (RF), calculated yield grade, or marbling scores. A quadratic increase (P = 0.01) in hot carcass weight (HCW) and a linear increase (P = 0.01) in ribeye area (REA) were detected. No significant implant × day interaction (P ≥ 0.09) was noted for serum concentrations of urea-N or IGF-I. Implants decreased (P = 0.01) SUN compared with NI. Serum concentration of IGF-I was increased (P = 0.04) in implanted steers compared with NI steers. In yearling crossbred beef steers, the use of steroidal implants containing a combination of 100 mg TBA + 14 mg EB or 200 mg TBA + 28 mg EB increases growth performance, HCW, and REA at equal RF accumulation without detriment to marbling score compared with nonimplanted steers.

Keywords: estradiol; growth performance; implant; trenbolone acetate.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Effect of implant treatment on serum concentration of urea-N (SUN) in finishing steers (n = 10 pens/treatment; pooled implant × day SEM = 0.206). Day 0 SUN values were included as a covariate (P = 0.01) in the model. Treatments were: 1) negative control given NI; 2) a steroidal implant containing 100 mg TBA and 14 mg EB administered subcutaneously in the center one-third of the ear on day 1 (Synovex Choice, Zoetis, Parsippany, NJ; CH); 3) a steroidal implant containing 200 mg TBA and 28 mg estradiol benzoate administered subcutaneously in the center one-third of the ear on day 1 (Synovex Plus, Zoetis; PL).
Figure 2.
Figure 2.
Effect of implant treatment on serum concentration of insulin-like growth factor I (IGF-I) in finishing steers (n = 10 pens/treatment; pooled implant × day SEM = 26.376). Day 0 IGF-I values were included as a covariate (P = 0.06) in the model. Treatments were: 1) negative control given NI; 2) a steroidal implant containing 100 mg TBA and 14 mg EB administered subcutaneously in the center one-third of the ear on day 1 (Synovex Choice, Zoetis, Parsippany, NJ; CH); 3) a steroidal implant containing 200 mg TBA and 28 mg EB administered subcutaneously in the center one-third of the ear on day 1 (Synovex Plus, Zoetis; PL).

References

    1. AOAC 2007. Official methods of analysis. 18th ed. Association of Official Analytical Chemist, Arlington, VA.
    1. AOAC 2016. Official Methods of Analysis of AOAC International. 20th ed. Association of Official Analytical Chemist, Arlington, VA.
    1. AOAC 2012. Official methods of analysis. 19th ed. Association of Official Analytical Chemist, Arlington, VA.
    1. Bartle S J, Preston R L, Brown R E, and Grant R J. . 1992. Trenbolone acetate/estradiol combinations in feedlot steers: dose-response and implant carrier effects. J. Anim. Sci. 70:1326–1332. doi:10.2527/1992.7051326x - DOI - PubMed
    1. Bruns K W, Pritchard R H, and Boggs D L. . 2005. The effect of stage of growth and implant exposure on performance and carcass composition in steers. J. Anim. Sci. 83:108–116. doi:10.2527/2005.831108x - DOI - PubMed

LinkOut - more resources